Results 141 to 150 of about 50,182 (219)

Slide positivity, trends, and risk factors of febrile Plasmodium vivax malaria along the Thailand-Myanmar border, 2018-2023. [PDF]

Infect Dis Poverty
Aung PL, Rachaphaew N, Sripoorote P, Htwe KZZ, Suk-Aum K, Kaewkungwal J, Lawpoolsri S, Cui L, Sattabongkot J.   +8 more
europepmc   +1 more source

Plasmodium vivax Malaria in Duffy-Positive Patients in Rwanda. [PDF]

Am J Trop Med Hyg, 2023
van Loon W, Oliveira R, Bergmann C, Habarugira F, Tacoli C, Jäger J, Savelsberg D, Mbarushimana D, Ndoli JM, Sendegeya A, Bayingana C, Mockenhaupt FP.   +11 more
europepmc   +1 more source

Splenic infarction in a paediatric patient with Plasmodium vivax malaria from Ethiopia: a case report. [PDF]

Malar J
Tekle AB, Bekele TT, Solbamo AB, Kebede MA, Berhanu MT, Baramo DD.   +5 more
europepmc   +1 more source

The importance of pathogen load. [PDF]

, 2015
Cunnington, AJ
core   +2 more sources

Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis. [PDF]

Malar J
Edler P, Rajasekhar M, Price DJ, Adam I, Awab GR, Barber BE, Brasil LW, Chamma-Siqueira NN, Chu CS, Cui L, Daher A, Gomes MDSM, Gonzalez-Ceron L, Grigg MJ, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Leslie T, Ley B, Lidia K, Llanos-Cuentas A, Longley RJ, Manning L, Mekonnen DA, Monteiro WM, Moore BR, Nosten F, Pasaribu AP, Pereira DB, Poespoprodjo JR, Pukrittayakamee S, Rijal KR, Saravu K, Siqueira AM, Sutanto I, Taylor WRJ, Thanh PV, Thriemer K, Vieira JLF, White NJ, Yeshiwondim AK, Zuluaga-Idarraga LM, Guerin PJ, Simpson JA, Price RN, Commons RJ, WorldWide Antimalarial Resistance Network (WWARN) Vivax Primaquine Dosing Efficacy, Tolerability and Safety Study Group.   +47 more
europepmc   +1 more source

Drug resistant Plasmodium vivax malaria [PDF]

Journal of Antimicrobial Chemotherapy, 1997
openaire   +2 more sources

Enhancing Primaquine Adherence for Plasmodium vivax Malaria: A Cluster-Randomized Controlled Trial in Myanmar. [PDF]

Am J Trop Med Hyg
Win KM, Aung PL, Linn NYY, Ring Z, Kyaw MP, Nguitragool W, Cui L, Sattabongkot J, Lawpoolsri S.   +8 more
europepmc   +1 more source

Severe Plasmodium vivax Malaria: Fact or Fiction? [PDF]

Clinical Infectious Diseases, 2012
S. Antinori, L. Milazzo, A. Ridolfo, L. Galimberti, M. Corbellino   +4 more
openaire   +3 more sources

FocaL mass drug administration for Plasmodium vivax malaria elimination (FLAME): study protocol for an open-label cluster randomized controlled trial in Peru. [PDF]

Trials
Fine SR, Soto Calle V, Altamirano Quiroz A, Rodriquez Ferruci H, Manrique P, Wu X, Carrasco Escobar G, Benjamin-Chung J, Bennett A, Auburn S, Price RN, Greenhouse B, Baird JK, Domingo GJ, Roh ME, Rosas A, Llanos-Cuentas A, Hsiang MS.   +17 more
europepmc   +1 more source

Acute Myocarditis in the Setting of Plasmodium vivax Malaria: A Case Report and Review of the Literature. [PDF]

Am J Trop Med Hyg
Talreja S, Bhellum P, Meena DS, Kaur N, Chhaba N, Khichar S.   +5 more
europepmc   +1 more source